• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

News

Article

Day 1 Recap: SDPA Annual Summer Dermatology Conference 2025

Key Takeaways

  • The 2025 SDPA Annual Summer Dermatology Conference offers dermatology PAs the latest specialty advancements and networking opportunities.
  • Dermatology Times board members will present clinical insights and practice-changing perspectives at the conference.
SHOW MORE

Catch up on coverage from the first day of the 2025 SDPA Annual Summer Dermatology Conference held in Washington, DC.

Dermatology Times SDPA Recap logo

To stay informed with the latest conference insights, subscribe to receive our eNewsletters.

Previewing the 2025 SDPA Annual Summer Dermatology Conference: What to Expect

The conference aimed at providing dermatology physician assistants with the latest in the specialty begins today in Washington, DC.

Inside SDPA Summer 2025: Dermatology Times Board Member Presenters

Join Dermatology Times at SDPA 2025 as our expert board members take the stage to share clinical insights, pearls, and practice-changing perspectives.

POLL: What Topic Are You Most Looking Forward to at SDPA Summer 2025?

Click here to answer our poll and let us know what you're looking forward to at the SDPA's summer conference.

From Conference to Clinic: Eileen Cheever, MPAS, PA-C, Looks Ahead to Pearls Offered at SDPA Summer Meeting

Eileen Cheever, MPAS, PA-C, previews the SDPA Summer Dermatology Conference, calling it a can't-miss opportunity to learn, network, and reconnect.

DFD-29 Data Analysis Highlights Efficacy in Rosacea Regardless of Patient Differences in Body Weight

DFD-29 showed strong efficacy in rosacea regardless of body weight in 2 phase 3 trials, outperforming both placebo and doxycycline.

Addressing Cutaneous Squamous Cell Carcinoma Through Early Detection and Treatment

A poster at SDPA 2025 highlights the importance of early biopsy and genetic testing in aggressive cSCC, even in young patients without classic risk factors.

Make sure to keep up to date with the latest in coverage from the conference and subscribe to Dermatology Times to receive daily email updates.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Videos
© 2025 MJH Life Sciences

All rights reserved.